FitzPatrick Margaret M
- SEC CIK
- 0001873879
In the past year, 1 open-market purchase filing worth $11.6K and no sales.
Current role at each company
- ANTX AN2 Therapeutics, Inc.Directoras of Sep 2, 2026
- VTGN Vistagen Therapeutics, Inc.Directoras of Sep 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $11.6K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$11.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists FitzPatrick Margaret M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ANTX AN2 Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)6:43 PM ET | Sep 1 | 1 day | FitzPatrick Margaret MDirector | PPurchase | +2.10K | $5.53 | +$11.6K | +24.4%10.7K after | |
| May 29, 2025 (view filing) | May 28 | 1 day | FitzPatrick Margaret MDirector | PPurchase | +8.61K | $1.18 | +$10.2K | New position8.61K after |